z-logo
open-access-imgOpen Access
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.
Author(s) -
Chaitanya R. Acharya,
David S. Hsu,
Carey K. Anders,
Ariel Anguiano,
Kelly H. Salter,
Kelli Walters,
Richard C. Redman,
Sascha A. Tuchman,
Cynthia A. Moylan,
Sayan Mukherjee,
William T. Barry,
Holly K. Dressman,
Geoffrey S. Ginsburg,
Kelly P. Marcom,
Katherine S. Garman,
Gary H. Lyman,
Joseph R. Nevins,
Anil Potti
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2012.2
Subject(s) - medicine , breast cancer , alternative medicine , precision medicine , cancer , chemotherapy , medline , family medicine , oncology , pathology , political science , law
To the Editor: We would like to retract the article entitled “Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer,” which was published in the April 2, 2008, issue of JAMA. A component of this article reported the use of chemotherapy sensitivity predictions based on an approach described by Potti et al in Nature Medicine in 2006. The Nature Medicine article was recently retracted due to an inability to reproduce the results with the chemotherapy signatures. Because a significant component of this JAMA article was based on the use of chemotherapy signatures reported in the Nature Medicine paper, we have decided to retract the JAMA article. We apologize for any negative impact on scientific research or clinical care caused by the publication of our article in JAMA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom